Monash University is a public research university based in Melbourne, Victoria, Australia. Named for prominent World War I general Sir John Monash, it was founded in 1958 and is the second oldest university in the state. The university has a number of campuses, four of which are in Victoria, and one in Malaysia.

During the past decade, Monash University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monash University" #1 sponsor was "Monash University" with 5 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored, "CHDI Foundation, Inc." with 1 trials sponsored and "Erasmus Medical Center" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monash University" #1 collaborator was "Monash University" with 3 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "University of Sydney" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Austin Hospital, Melbourne Australia" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Monash University" are "Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Adherence, Medication" (1 trials), "Alzheimer's Disease" (1 trials) and "Cardiothoracic Surgery" (1 trials). Many other conditions were trialed in "Monash University" in a lesser frequency.

Most popular intervention types in "Monash University" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Ambulatory Oxygen Therapy" (1 trials), "Biparametric MRI +/- prostate biopsy" (1 trials) and "Cladribine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monash University" are 14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Monash University". 1 are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Monash University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monash University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Monash University has several departments that took part in Clinical trials: "Clinical Research Unit, Infectious Diseases" - 2 trials, "Women's Health Research Program, Monash University, The Alfred Hospital" - 2 trials